246 related articles for article (PubMed ID: 15492629)
1. Risk factors for retention of subretinal perfluorocarbon liquid in vitreoretinal surgery.
Garcia-Valenzuela E; Ito Y; Abrams GW
Retina; 2004 Oct; 24(5):746-52. PubMed ID: 15492629
[TBL] [Abstract][Full Text] [Related]
2. Submacular perfluorocarbon liquid: long-term follow-up.
Ghoraba HH; Ghoraba HH; Heikal MA; Elgouhary SM; Mansour HO; Abdelhafez MA; Zaky AG
Int Ophthalmol; 2020 May; 40(5):1209-1219. PubMed ID: 31981001
[TBL] [Abstract][Full Text] [Related]
3. Perfluorocarbon liquid in the management of retinal detachment with proliferative vitreoretinopathy.
Coll GE; Chang S; Sun J; Wieland MR; Berrocal MH
Ophthalmology; 1995 Apr; 102(4):630-8; discussion 638-9. PubMed ID: 7724180
[TBL] [Abstract][Full Text] [Related]
4. Changes in retinal sensitivity from retained subretinal perfluorocarbon liquid.
Tewari A; Eliott D; Singh CN; Garcia-Valenzuela E; Ito Y; Abrams GW
Retina; 2009 Feb; 29(2):248-50. PubMed ID: 18854788
[TBL] [Abstract][Full Text] [Related]
5. Release and extraction of retained subfoveal perfluorocarbon liquid facilitated by subretinal BSS, vibration, and gravity: a case report.
Takahashi K; Kimura S; Hosokawa MM; Shiode Y; Doi S; Matoba R; Kanzaki Y; Yonekawa Y; Morizane Y
BMC Ophthalmol; 2020 Oct; 20(1):427. PubMed ID: 33097007
[TBL] [Abstract][Full Text] [Related]
6. The use of perfluorocarbon liquids in vitreoretinal surgery.
Crafoord S; Larsson J; Hansson LJ; Carlsson JO; Stenkula S
Acta Ophthalmol Scand; 1995 Oct; 73(5):442-5. PubMed ID: 8751125
[TBL] [Abstract][Full Text] [Related]
7. Intraocular mitomycin C use in the treatment and prophylaxis of proliferative vitreoretinopathy in severe traumatic retinal detachments.
Gürelik G; Sül S; Üçgül AY
Eur J Ophthalmol; 2021 Nov; 31(6):3284-3293. PubMed ID: 33233948
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.
Scott IU; Flynn HW; Murray TG; Feuer WJ;
Am J Ophthalmol; 2003 Sep; 136(3):454-63. PubMed ID: 12967798
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane.
Scott IU; Murray TG; Flynn HW; Feuer WJ; Schiffman JC;
Ophthalmology; 2002 Oct; 109(10):1828-33. PubMed ID: 12359602
[TBL] [Abstract][Full Text] [Related]
10. Perfluorocarbon Liquid Vs. Subretinal Fluid Drainage during Vitrectomy for the Primary Repair of Rhegmatogenous Retinal Detachment: A Comparative Study.
Vidne O; Blum Meirovitch S; Rabina G; Abd Eelkader A; Prat D; Barequet D; Moisseiev J; Moisseiev E
Curr Eye Res; 2018 Nov; 43(11):1389-1394. PubMed ID: 29912572
[TBL] [Abstract][Full Text] [Related]
11. Development and initial experience with a colored perfluorocarbon liquid for intraocular tamponade in vitreoretinal surgery.
Rodrigues EB; Shiroma H; Penha FM; Maia M; Moraes-Filho MN; Ferreira M; Portella R; Novais E; Hagedorn N; Farah ME
Retina; 2014 Jun; 34(6):1103-11. PubMed ID: 24480841
[TBL] [Abstract][Full Text] [Related]
12. Displacement of retained subfoveal perfluorocarbon liquid after vitreoretinal surgery.
Le Tien V; Pierre-Kahn V; Azan F; Renard G; Chauvaud D
Arch Ophthalmol; 2008 Jan; 126(1):98-101. PubMed ID: 18195225
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Using Perfluorocarbon Liquid as Postoperative Tamponade in Complex Inferior Retinal Detachments.
Naz S; Naz U; Fahad HM; Rizvi SF
J Coll Physicians Surg Pak; 2022 Nov; 32(11):1454-1458. PubMed ID: 36377014
[TBL] [Abstract][Full Text] [Related]
14. Management options for submacular perfluorocarbon liquid.
Suk KK; Flynn HW
Ophthalmic Surg Lasers Imaging; 2011; 42(4):284-91. PubMed ID: 21800801
[TBL] [Abstract][Full Text] [Related]
15. Management of complex retinal detachment with combined relaxing retinotomy and intravitreal perfluoro-n-octane injection.
Han DP; Rychwalski PJ; Mieler WF; Abrams GW
Am J Ophthalmol; 1994 Jul; 118(1):24-32. PubMed ID: 8023872
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes of Endoscope-Assisted Vitreous Surgery for Giant Retinal Tear Detachment.
Mitamura H; Kaga T; Yokoyama S; Kojima T; Mori T; Matsuda T; Sato H; Yoshida N; Ichikawa K
Ophthalmic Res; 2021; 64(5):820-827. PubMed ID: 34062537
[TBL] [Abstract][Full Text] [Related]
17. Management of Subfoveal Perfluorocarbon Liquid: A Review.
Liu W; Gao M; Liang X
Ophthalmologica; 2018; 240(1):1-7. PubMed ID: 29669355
[TBL] [Abstract][Full Text] [Related]
18. Results of 12-year clinical study of giant retinal tear.
Chen CH; Tsai MH; Su CC; Kou HK; Kao ML; Tsai SH; Chen YJ
Chang Gung Med J; 2001 Oct; 24(10):633-9. PubMed ID: 11771186
[TBL] [Abstract][Full Text] [Related]
19. Soft shell technique during vitrectomy for proliferative vitreoretinopathy.
Yamakiri K; Uchino E; Sakamoto T
Graefes Arch Clin Exp Ophthalmol; 2016 Jun; 254(6):1069-73. PubMed ID: 26340867
[TBL] [Abstract][Full Text] [Related]
20. Subretinal fluid drainage via original retinal breaks for rhegmatogenous retinal detachment.
Yamaguchi M; Ataka S; Shiraki K
Can J Ophthalmol; 2014 Jun; 49(3):256-60. PubMed ID: 24862771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
